House Holds a Joint Meeting on Acceleration of Covid-19 Handling
A Vice Speaker of the House, Rachmat Gobel, opened a virtual joint working meeting and hearing attended by three House’s Commissions, four Ministers and five heads of agencies handling COVID-19. The commissions representing the House were Commission VI (industry, trade, state-owned enterprises, investment, national standard, cooperatives, and small and medium enterprises), Commission VII (energy, research and technology), and Commission IX (health, manpower, and demography), while the representatives of the government were the Minister of Research and Technology/the Head of National Agency for Research and Innovation, Minister of Industry, Minister of State-Owned Enterprises and the Minister of Health. Meanwhile, the five heads of agencies were the Head of Agency for the Assessment and Application of Technology (BPPT), the Head of Indonesian Institute of Sciences (LIPI), the Head of National Institute of Aeronautics and Space (LAPAN), the Head of Indonesian Food and Drug Monitoring Agency (BPOM), and the Head of Eijkman Institute for Molecular Biology.
The joint meeting and hearing was held as the implementation of oversight function. Issues of acceleration of prevention and handling of COVID-19 pandemic in Indonesia, coordination, downstreaming, and commercialization on the consortium’s COVID-19 research and innovation products in the handling of COVID-19 pandemic; and acceleration of studies and development of vaccines and drugs for COVID-19 in Indonesia were put on the agenda.
“The global COVID-19 pandemic that Indonesia is facing has brought about an alarming situation. As we all know, according to the current data, the number of positive cases of coronavirus in Indonesia has reached 11,587 people. That is a high number and it spreads quite massively and evenly. The positive cases can be found from big cities to small villages,” said Gobel when opening the meeting in Parliamentary Complex, Senayan, Jakarta, Tuesday (5/5/2020).
He also said that the pandemic had undeniably made complex and widespread impacts. Handling COVID-19 pandemic in Indonesia is a race against time. Gobel explained that pandemic-related problems faced by the government are the lack of ventilators and COVID-19 testing kits, and several other problems.
“As we all know, the Ministry of Research and Technology/National Agency for Research and Innovation has formed a consortium of research and innovation on COVID-19 to support the tasks of COVID-19 Task Force in the fields of research, studies, and applications,” he added.
Gobel added that the consortium’s products, among others are the development of health equipment which will be one of the solutions to solve the government’s shortage. “Therefore, good supports and coordination from all related elements are needed,” he stressed.
After opening and giving his opening remarks at the virtual meeting, the Vice Speaker, Coordinator for Industry and Development, passed the gavel to the Chairman of the Commission VII of the House, Sugeng Suparwoto to chair the meeting.
On that occasion, Suparwoto read out a report of the Working Meeting/Hearing of the Commission VII with the Minister of Research and Technology/the Head of the National Research Agency, BPPT, LIPI, LAPAN, and the Director of Eijkman Biology Molecular Institute (LBM) on 14 April 2020. One of the conclusions said that the Commission VII through the consortium of research and innovation on Covid-19 called on the Minister of Research and Technology/the Head of National Research Agency to accelerate the implementation of consortium programs, among others are the development of portable ventilator, development of Covid-19 vaccine and medicine and mapping of COVID-19 handling and its priority steps.
Suparwoto stressed that the acceleration could only be achieved through comprehensive coordination and supports from all the related parties. Therefore, Commission VII held the Joint Working Meeting and Hearing for the realization of acceleration of prevention and control of COVID-19 pandemic in Indonesia.
“We specifically want to elaborate how far the progress has been made on matters related to the coordination, down streaming, and the commercialization of products developed from the consortium of COVID-19 research and innovation in the acceleration of prevention and control of COVID-19 in Indonesia and to update the research and invention of COVID-19 vaccine and medicine in Indonesia,” Suparwoto concluded.